Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MOH Arranges Centralized Drug Purchase Work

This article was originally published in PharmAsia News

Executive Summary

At a working meeting for national centralized drug purchase, Ministry of Health Deputy Minister Gao Qiang pointed out that such a system is the objective requirement of deepening the health care system reform and plays an important role. Centralized purchase will: improve the channels for ensuring drug supply as a centralized tender and competitive bidding process can increase drug purchase efficiency and effective supervision of unreasonable pricing; facilitate the establishment of a reasonable drug-price formulation mechanism; and promote pharmaceutical industry optimization and upgrades. Drug companies may redeploy marketing resources in good product development, quality enhancement and competitive building. (Click here for more - Chinese Language)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC069922

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel